Mostrar el registro sencillo del ítem

dc.contributor.authorPham, Thu Thi
dc.contributor.authorSánchez Pérez, María José 
dc.date.accessioned2022-12-12T12:47:27Z
dc.date.available2022-12-12T12:47:27Z
dc.date.issued2022-11-09
dc.identifier.citationPham, T.-T... [et al.]. Pre-Diagnostic Circulating Resistin Concentrations Are Not Associated with Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Study. Cancers 2022, 14, 5499. [https://doi.org/10.3390/cancers14225499]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/78400
dc.description.abstractResistin is a polypeptide implicated in inflammatory processes, and as such could be linked to colorectal carcinogenesis. In case-control studies, higher resistin levels have been found in colorectal cancer (CRC) patients compared to healthy individuals. However, evidence for the association between pre-diagnostic resistin and CRC risk is scarce. We investigated pre-diagnostic resistin concentrations and CRC risk within the European Prospective Investigation into Cancer and Nutrition using a nested case-control study among 1293 incident CRC-diagnosed cases and 1293 incidence density-matched controls. Conditional logistic regression models controlled for matching factors (age, sex, study center, fasting status, and women-related factors in women) and potential confounders (education, dietary and lifestyle factors, body mass index (BMI), BMI-adjusted waist circumference residuals) were used to estimate relative risks (RRs) and 95% confidence intervals (CIs) for CRC. Higher circulating resistin concentrations were not associated with CRC (RR per doubling resistin, 1.11; 95% CI 0.94–1.30; p = 0.22). There were also no associations with CRC subgroups defined by tumor subsite or sex. However, resistin was marginally associated with a higher CRC risk among participants followed-up maximally two years, but not among those followed-up after more than two years. We observed no substantial correlation between baseline circulating resistin concentrations and adiposity measures (BMI, waist circumference), adipokines (adiponectin, leptin), or metabolic and inflammatory biomarkers (C-reactive protein, C-peptide, high-density lipoprotein cholesterol, reactive oxygen metabolites) among controls. In this large-scale prospective cohort, there was little evidence of an association between baseline circulating resistin concentrations and CRC risk in European men and women.es_ES
dc.description.sponsorshipWorld Health Organizationes_ES
dc.description.sponsorshipDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College Londones_ES
dc.description.sponsorshipDanish Cancer Societyes_ES
dc.description.sponsorshipLigue contre le Cancer (France)es_ES
dc.description.sponsorshipInstitut Gustave Roussy (France)es_ES
dc.description.sponsorshipMutuelle Generale de l'Education Nationale (France)es_ES
dc.description.sponsorshipInstitut National de la Sante et de la Recherche Medicale (Inserm)es_ES
dc.description.sponsorshipDeutsche Krebshilfees_ES
dc.description.sponsorshipFederal Ministry of Education & Research (BMBF)es_ES
dc.description.sponsorshipHellenic Health Foundation (Greece)es_ES
dc.description.sponsorshipFondazione AIRC per la ricerca sul cancroes_ES
dc.description.sponsorshipConsiglio Nazionale delle Ricerche (CNR)es_ES
dc.description.sponsorshipNetherlands Government Netherlands Governmentes_ES
dc.description.sponsorshipWorld Cancer Research Fund International (WCRF)es_ES
dc.description.sponsorshipNetherlands Governmentes_ES
dc.description.sponsorshipNordforsk, Nordic Centre of Excellence programme on Food, Nutrition and Health (Norway)es_ES
dc.description.sponsorshipInstituto de Salud Carlos IIIes_ES
dc.description.sponsorshipJunta de Andaluciaes_ES
dc.description.sponsorshipPrincipality of Asturiases_ES
dc.description.sponsorshipRegional Government of Basque Country (Spain)es_ES
dc.description.sponsorshipRegional Government of Murcia (Spain)es_ES
dc.description.sponsorshipRegional Government of Navarra (Spain)es_ES
dc.description.sponsorshipInstituto de Salud Carlos III RD06/0020es_ES
dc.description.sponsorshipSwedish Cancer Societyes_ES
dc.description.sponsorshipSwedish Scientific Council (Sweden)es_ES
dc.description.sponsorshipRegional Government of Skane and Vasterbotten (Sweden)es_ES
dc.description.sponsorshipUK Research & Innovation (UKRI)es_ES
dc.description.sponsorshipMedical Research Council UK (MRC)es_ES
dc.description.sponsorshipCancer Research UKes_ES
dc.description.sponsorshipNetherlands Governmentes_ES
dc.description.sponsorshipDeutsches Krebsforschungszentrum (Germany) ERC-2009-AdG 232997es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectPre-diagnostic resistines_ES
dc.subjectColorectal canceres_ES
dc.subjectRiskes_ES
dc.subjectProspectivees_ES
dc.subjectInflammation es_ES
dc.titlePre-Diagnostic Circulating Resistin Concentrations Are Not Associated with Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Studyes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/cancers14225499
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional